Merck & Co (NYSE: $MRK) is a multinational pharmaceutical company that offers innovative health solutions to millions of patients via prescriptions, therapies, vaccines, and animal […]
Tag: MRK
Merck’s (NASDAQ: $MRK) $680M Harpoon Therapeutics Acquisition Further Diversifies Oncology Pipeline
Merck & Co. (NASDAQ: $MRK) will acquire Harpoon Therapeutics for $680 million in a push to consolidate its leadership position in the oncology space. According […]